mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |